Unravelling the Potential of Atrasentan Beyond IgAN: Integrating Biomarker, Genetic & Clinical Data to Identify Future Indications
Time: 11:00 am
day: Conference Day One Track B AM
Details:
- Preliminary data from AFFINITY in FSGS, Alport’s and DKD cohorts
- Genetic, transcriptomic, and proteomic profiling to understand failed tubular repair
- Integrating these diverse types of data to identify promising additional indications
